Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine

NCT07418229 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV
mRNA Vaccine

Interventions

BIOLOGICAL: Low-dose RSV mRNA vaccine
BIOLOGICAL: High-dose RSV mRNA vaccine
OTHER: Placebo

Sponsor

Sinovac Biotech Co., Ltd